• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    6/5/23 12:23:06 PM ET
    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $AGLE alert in real time by email

     

    Monday's session saw 41 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • The largest company in terms of market cap to set a new 52-week low was EPAM Sys (NYSE:EPAM).
    • The company with the smallest market cap to set a new 52-week low was Oncorus (NASDAQ:ONCR).
    • Castle Biosciences (NASDAQ:CSTL) was the biggest loser, trading down 46.96% to reach its 52-week low.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares actually gained 0.23%, rebounding after it reached its 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • EPAM Sys (NYSE:EPAM) shares made a new 52-week low of $210.40 on Monday. The stock was down 17.79% for the day.
    • Endava (NYSE:DAVA) stock drifted down 11.15% on Monday morning to hit a new 52-week low of $45.73.
    • Canopy Gwth (NASDAQ:CGC) stock hit a yearly low of $0.77. The stock was down 5.49% for the day.
    • Blink Charging (NASDAQ:BLNK) shares fell to $6.42 on Monday, setting a new 52-week low with a shift of down 2.94%.
    • Castle Biosciences (NASDAQ:CSTL) shares moved down 46.96% on Monday to hit a new 52-week low of $9.26, drifting down 46.96%.
    • Zumiez (NASDAQ:ZUMZ) stock set a new 52-week low of $13.38 on Monday, moving down 11.6%.
    • LivePerson (NASDAQ:LPSN) stock achieved a new 52-week low on Monday morning, hitting $3.31 and moving down 11.33%.
    • Eagle Pharmaceuticals (NASDAQ:EGRX) stock drifted down 11.7% on Monday morning to hit a new 52-week low of $18.73.
    • Inogen (NASDAQ:INGN) stock hit a yearly low of $9.88. The stock was down 6.56% for the day.
    • Tredegar (NYSE:TG) shares were down 12.53% for the day, having made a 52-week low of $6.58.
    • Genesco (NYSE:GCO) stock achieved a new 52-week low on Monday morning, hitting $17.32 and moving down 6.14%.
    • Tilly's (NYSE:TLYS) stock drifted down 4.28% on Monday morning to hit a new 52-week low of $6.15.
    • ClearPoint Neuro (NASDAQ:CLPT) stock drifted down 6.17% on Monday morning to hit a new 52-week low of $7.15.
    • Southern States (NASDAQ:SSBK) stock achieved a new 52-week low on Monday morning, hitting $19.61 and moving down 1.74%.
    • Cara Therapeutics (NASDAQ:CARA) stock set a new 52-week low of $2.94 on Monday, moving up 0.97%.
    • DZS (NASDAQ:DZSI) shares set a new yearly low of $3.30 this morning. The stock was down 1.59% on the session.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares were up 0.23% for the day, having made a 52-week low of $4.13.
    • Cue Health (NASDAQ:HLTH) stock achieved a new 52-week low on Monday morning, hitting $0.52 and moving down 9.65%.
    • PhenomeX (NASDAQ:CELL) stock dropped to a yearly low on Monday of $0.59. Shares traded down 4.9%.
    • Wheels Up Experience (NYSE:UP) shares reached a new 52-week low of $0.23 on Monday morning, moving up 2.04%.
    • Lordstown Motors (NASDAQ:RIDE) stock achieved a new 52-week low on Monday morning, hitting $3.10 and moving down 2.53%.
    • AmeriServ Financial (NASDAQ:ASRV) stock dropped to a yearly low on Monday of $2.70. Shares traded up 2.3%.
    • CuriosityStream (NASDAQ:CURI) stock hit a new 52-week low of $0.81. The stock was down 6.18% on the session.
    • CaliberCos (NASDAQ:CWD) stock set a new 52-week low of $2.01 on Monday, moving down 4.63%.
    • PIMCO New York Municipal (NYSE:PYN) shares fell to $6.01 on Monday, setting a new 52-week low with a shift of down 0.8%.
    • Comstock Holding Co (NASDAQ:CHCI) stock dropped to a yearly low on Monday of $3.63. Shares traded down 1.21%.
    • Rubicon Technologies (NYSE:RBT) stock hit a yearly low of $0.33. The stock was down 10.53% for the day.
    • The Real Good Food (NASDAQ:RGF) shares reached a new 52-week low of $3.35 on Monday morning, moving down 0.85%.
    • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved down 6.01% on Monday to hit a new 52-week low of $0.48, drifting down 6.01%.
    • Hempacco (NASDAQ:HPCO) shares were down 0.33% for the day, having made a 52-week low of $0.47.
    • Greenidge Generation Hldg (NASDAQ:GREE) stock drifted down 0.69% on Monday morning to hit a new 52-week low of $2.10.
    • Wejo Gr (NASDAQ:WEJO) shares set a new 52-week low of $0.08. The stock traded up 7.37%.
    • Comera Life Sciences (NASDAQ:CMRA) stock hit $0.39 on Monday morning, setting a new 52-week low for a change of up 5.0%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares moved down 2.34% on Monday to hit a new 52-week low of $0.12, drifting down 2.34%.
    • Ambow Education Holding (AMEX:AMBO) shares set a new 52-week low of $0.21. The stock traded down 0.48%.
    • Staffing 360 Solutions (NASDAQ:STAF) stock set a new 52-week low of $0.88 on Monday, moving down 9.98%.
    • Sigma Additive Solutions (NASDAQ:SASI) shares were down 8.34% for the day, having made a 52-week low of $0.30.
    • Oncorus (NASDAQ:ONCR) stock drifted down 10.35% on Monday morning to hit a new 52-week low of $0.09.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AGLE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGLE
    $AMBO
    $ASRV
    $BLNK

    CompanyDatePrice TargetRatingAnalyst
    EPAM Systems Inc.
    $EPAM
    1/6/2026$220.00Hold
    Truist
    Endava plc
    $DAVA
    11/12/2025$12.00 → $9.00Buy
    Needham
    Endava plc
    $DAVA
    11/11/2025Outperform → Mkt Perform
    William Blair
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    EPAM Systems Inc.
    $EPAM
    10/23/2025$170.00Neutral
    Citigroup
    EPAM Systems Inc.
    $EPAM
    10/22/2025$185.00Overweight
    Wells Fargo
    Endava plc
    $DAVA
    9/5/2025$20.00 → $18.00Buy
    Guggenheim
    Genesco Inc.
    $GCO
    8/26/2025$38.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Senior VP Gray Andrew was granted 34,579 shares, increasing direct ownership by 63% to 89,136 units (SEC Form 4)

    4 - GENESCO INC (0000018498) (Issuer)

    2/6/26 4:05:03 PM ET
    $GCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 4 filed by Director Hendricks John S

    4 - CuriosityStream Inc. (0001776909) (Issuer)

    2/6/26 1:15:45 PM ET
    $CURI
    Movies/Entertainment
    Consumer Discretionary

    Director Hendricks Elizabeth Ann converted options into 38,500 shares, increasing direct ownership by 29% to 172,785 units (SEC Form 4)

    4 - CuriosityStream Inc. (0001776909) (Issuer)

    2/6/26 12:51:06 PM ET
    $CURI
    Movies/Entertainment
    Consumer Discretionary

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bercovich Michael bought $50,392 worth of shares (65,333 units at $0.77), increasing direct ownership by 53% to 188,563 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:08:54 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    President and CEO Battaglia Michael C. bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 14% to 267,095 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    12/12/25 6:07:33 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    Control Person of Adviser Gabelli Mario J bought $214,300 worth of shares (50,000 units at $4.29), increasing direct ownership by 11% to 486,501 units (SEC Form 4)

    4 - GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC (0000845611) (Issuer)

    11/19/25 2:33:13 PM ET
    $GCV
    Finance/Investors Services
    Finance

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on EPAM Systems with a new price target

    Truist initiated coverage of EPAM Systems with a rating of Hold and set a new price target of $220.00

    1/6/26 8:56:08 AM ET
    $EPAM
    EDP Services
    Technology

    Needham reiterated coverage on Endava with a new price target

    Needham reiterated coverage of Endava with a rating of Buy and set a new price target of $9.00 from $12.00 previously

    11/12/25 8:03:22 AM ET
    $DAVA
    EDP Services
    Technology

    Endava downgraded by William Blair

    William Blair downgraded Endava from Outperform to Mkt Perform

    11/11/25 12:46:17 PM ET
    $DAVA
    EDP Services
    Technology

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    SEC Filings

    View All

    SEC Form 253G2 filed by CaliberCos Inc.

    253G2 - CaliberCos Inc. (0001627282) (Filer)

    2/6/26 5:00:23 PM ET
    $CWD
    Real Estate
    Finance

    SEC Form S-3 filed by Canopy Growth Corporation

    S-3 - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 4:15:52 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 7:05:59 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Endava to Announce Q2 FY2026 Financial Results on February 19, 2026

    Endava plc (NYSE:DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced it will release results for the second quarter ended December 31, 2025, on Thursday February 19, 2026 before the opening of regular U.S. market hours. Following the release, John Cotterell, Endava's CEO and Mark Thurston, Endava's CFO, will discuss the results in a conference call beginning at 8:00 am ET. Conference call access information is: Participant Toll Free Dial-In Number: 1-844-481-2736 Participant International Dial-In Number: 1-412-317-0665 Conference ID: Endava Call Webcast: https://investors.e

    2/5/26 4:22:00 PM ET
    $DAVA
    EDP Services
    Technology

    Wheels Up Announces Fernando Mendoza as Brand Ambassador

    Heisman Trophy-Winning and NCAA National Champion Quarterback Joins the Wheels Up Community ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP), one of the world's leading providers of on-demand private aviation, today announced that NCAA National Champion and 2025 Heisman Trophy winner Fernando Mendoza is a new addition to the Wheels Up Ambassador community. Recognized as the most accomplished collegiate football player this season, Mendoza represents the next generation of elite athletes whose lives and careers demand flexibility, efficiency, and connectivity across every mode of travel.

    2/5/26 8:30:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Wheels Up Announces Date of Fourth Quarter 2025 Earnings Release

    ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that it will release its fourth quarter 2025 financial results on Thursday, February 19, 2026. Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading global provider of on-demand private aviation with a large, diverse fleet and a network of safety-vetted charter operators, all committed to safety and service. Customers access charter and membership programs and premium commercial travel benefits th

    2/5/26 8:00:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Leadership Updates

    Live Leadership Updates

    View All

    EPAM to Host Investor Day on March 12, 2026

    Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation NEWTOWN, Pa., Jan. 13, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital and AI transformation company, will host an Investor Day in Boston on March 12, 2026. The event will feature remarks by EPAM's Chief Executive Officer and President, Balazs Fejes, and Chief Financial Officer, Jason Peterson, as well as other members of the executive leadership team. "Our Investor Day is an opportunity to demonstrate the solid progress we've made against our long-term strategic pr

    1/13/26 8:02:00 AM ET
    $EPAM
    EDP Services
    Technology

    Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth's presence in Québec with an opportunity to expand national distribution of MTL's high-quality, budtender-recommended product portfolio2 MTL's core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company's p

    12/15/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Tredegar Announces Retirement of John M. Steitz

    Arijit (Bapi) DasGupta Elected as President and Chief Executive Officer and to the Board of Directors; Frasier W. Brickhouse II Elected as Vice President and Chief Financial Officer Tredegar Corporation (NYSE:TG) today announced the retirement of John M. Steitz as its President and Chief Executive Officer and as a member of its Board of Directors (Board), effective December 31, 2025. The Board has elected Arijit (Bapi) DasGupta as Tredegar's President and Chief Executive Officer and as a member of its Board, effective January 1, 2026. Mr. Steitz has served as a director of Tredegar since 2018 and as its President and Chief Executive Officer since 2019. Dr. DasGupta joined Tredegar in 20

    11/20/25 4:47:00 PM ET
    $TG
    Metal Fabrications
    Industrials

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Financials

    Live finance-specific insights

    View All

    Endava to Announce Q2 FY2026 Financial Results on February 19, 2026

    Endava plc (NYSE:DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced it will release results for the second quarter ended December 31, 2025, on Thursday February 19, 2026 before the opening of regular U.S. market hours. Following the release, John Cotterell, Endava's CEO and Mark Thurston, Endava's CFO, will discuss the results in a conference call beginning at 8:00 am ET. Conference call access information is: Participant Toll Free Dial-In Number: 1-844-481-2736 Participant International Dial-In Number: 1-412-317-0665 Conference ID: Endava Call Webcast: https://investors.e

    2/5/26 4:22:00 PM ET
    $DAVA
    EDP Services
    Technology

    Wheels Up Announces Date of Fourth Quarter 2025 Earnings Release

    ATLANTA, Feb. 5, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that it will release its fourth quarter 2025 financial results on Thursday, February 19, 2026. Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading global provider of on-demand private aviation with a large, diverse fleet and a network of safety-vetted charter operators, all committed to safety and service. Customers access charter and membership programs and premium commercial travel benefits th

    2/5/26 8:00:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026

    FRIENDSWOOD, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the fourth quarter and year ended Dec. 31, 2025, after the close of market on Thursday, Feb. 26, 2026. Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day. Conference Call and Webcast DetailsA live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/483643109, or via the webcast link on the Investor Relations page of the Company's website: htt

    2/5/26 7:00:00 AM ET
    $CSTL
    Medical Specialities
    Health Care

    $AGLE
    $AMBO
    $ASRV
    $BLNK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Staffing 360 Solutions Inc.

    SC 13G/A - Staffing 360 Solutions, Inc. (0001499717) (Subject)

    11/14/24 5:15:11 PM ET
    $STAF
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Castle Biosciences Inc.

    SC 13G/A - CASTLE BIOSCIENCES INC (0001447362) (Subject)

    11/14/24 4:40:39 PM ET
    $CSTL
    Medical Specialities
    Health Care